# TKM 080301 for Primary or Secondary Liver Cancer

> **NCT01437007** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer With Hepatic Metastases
- Pancreas Cancer With Hepatic Metastase
- Gastric Cancer With Hepatic Metastase
- Breast Cancer With Hepatic Metastase
- Ovarian Cancer With Hepatic Metastase

## Interventions

- **DRUG:** TKM-080301

## Key facts

- **NCT ID:** NCT01437007
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-26
- **Primary completion:** 2012-06-21
- **Final completion:** 2012-06-21
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437007, "TKM 080301 for Primary or Secondary Liver Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01437007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*